Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

NEO/CBST stock hub

NEO/CBST has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

NEO/CBSTis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

21.7M

Cboe Canada

Market data

Live price

Current market quote for this ticker.

Current price

NEO/CBST

In the news

Latest news · NEO/CBST

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 11P50 15.6P75 25.4

Trailing P/En/a

P25 7.4P50 15.6P75 34.3

ROEn/a

P25 -121.5P50 -40.9P75 0.5

ROIC-17

P25 -72.5P50 -16P75 1.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All NEO/CBST market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

170

Groups with data

Currency

USD

Showing 170 of 170 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Canada
Country code	CA
Employees	1,681
Employees Change	-510%
Employees Change Percent	-23.28
Enterprise value	CAD 602.2M
Exchange	Cboe Canada
Financial currency	USD
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	CA13765Y1034
Last refreshed	2026-05-10
Market cap	CAD 21.7M
Price	CAD 0.04
Price currency	CAD
Rev Per Employee	289,880.21x
Sector	Healthcare
Sic	2834
Symbol	neo/CBST
Website	https://www.cannabistcompany.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-1,149.62%
EV Earnings	-2.42x
EV/EBITDA	12.11x
EV/FCF	-11.54x
EV/Sales	1.25x
FCF yield	-240.72%
P/B ratio	-0.1x
P/S ratio	0.04x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-13.62%
EBITDA Margin	-3.74%
Gross margin	29.51%
Gross Profit	CAD 143.8M
Gross Profit Growth	-42%
Gross Profit Growth Q	-47.7%
Gross Profit Growth3 Y	-22.49%
Gross Profit Growth5 Y	8.83%
Net Income	CAD -249.3M
Net Income Growth Years	2%
Pretax Margin	-36.04%
Profit Margin	-51.15%
Profit Per Employee	CAD -148,286
ROA	-4.56
Roa5y	-3.47
ROCE	-12.73
Roe5y	-182.7
ROIC	-17.01
Roic5y	-7.92

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-66.69%
Cagr3y	-61.63%
Cagr5y	-65.83%
EPS Growth Years	2
Revenue Growth	-28.74x
Revenue Growth Q	-30.38x
Revenue Growth Years	0x
Revenue Growth3 Y	-12.64x
Revenue Growth5 Y	22.54x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CAD 0.54
Assets	CAD 747.3M
Cash	CAD 26.3M
Current Assets	CAD 197.9M
Current Liabilities	CAD 221.6M
Debt	CAD 617.1M
Debt EBITDA	CAD 12.23
Debt FCF	CAD -11.82
Equity	CAD -213M
Interest Coverage	-1.04
Liabilities	CAD 960.3M
Long Term Assets	CAD 549.4M
Long Term Liabilities	CAD 738.7M
Net Cash	CAD -590.8M
Net Cash By Market Cap	CAD -2,725
Tangible Book Value	CAD -266M
Tangible Book Value Per Share	CAD -0.53
WACC	8.16

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.89
Inventory Turnover	3.15
Net Working Capital	CAD -34.6M
Quick ratio	0.21
Working Capital	CAD -24.2M
Working Capital Turnover	CAD -25.68

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-8.95%
Dividend per share	CAD 0
Last Dividend	CAD 0

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-66.67%
200-day SMA	0.09
3Y total return	-94.35%
50-day SMA	0.04
50-day SMA vs 200-day SMA	50under200
5Y total return	-99.53%
All Time High	11.95
All Time High Change	-99.71%
All Time High Date	2019-04-29
All Time Low	0.03
All Time Low Change	16.67%
All Time Low Date	2026-03-16
ATR	0
Beta	0.7
Ch YTD	-58.82
High	0.04
High52	0.23
High52 Date	2025-07-28
High52ch	-84.44%
Low	0.04
Low52	0.03
Low52 Date	2026-03-20
Low52ch	16.67%
Ma50ch	-2.51%
Price vs 200-day SMA	-61.11%
RSI	43.08
RSI Monthly	33.56
RSI Weekly	37.66
Sharpe ratio	0.21x
Sortino ratio	0.39
Total Return	-8.95%
Tr YTD	-58.82
Tr3m	-36.36%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CAD -66.4M
Operating margin	-13.62

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	520,820,193%
Net Borrowing	-9,107,287.1
Shares Insiders	3.22%
Shares Institutions	16.61%
Shares Qo Q	2.99%
Shares Yo Y	8.95%
Short Ratio	0.08

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CAD -56.5M
Average Volume	21,601.4x
Bv Per Share	-0.42
CAPEX	CAD -8.1M
Ch1y	-66.67
Ch3m	-36.36
Ch3y	-94.35
Ch5y	-99.53
Ch6m	-63.16
Change	0%
Change From Open	0
Close	0.04
Days Gap	0
Depreciation Amortization	47,258,918.5
Earnings Date	2026-03-30
EBIT	CAD -66.4M
EBITDA	CAD -18.2M
EPS	CAD -0.52
F Score	1
FCF	CAD -52.2M
FCF EV Yield	-8.67x
Financing CF	-26,398,051
Fiscal Year End	December
Founded	2,012
Income Tax	CAD 74.3M
Investing CF	50,788,948
Is Primary Listing	0
Last Earnings Date	2025-11-10
Last Report Date	2025-09-30
Ma150	0.07
Ma150ch	-47.45%
Ma20	0.04
Ma20ch	0%
Net CF	-19,742,823
Open	0.04
Ppne	447,013,046.6
Price Date	2026-05-06
Relative Volume	1.82x
Revenue	487,288,638x
SBC By Revenue	0.88x
Share Based Comp	4,270,601
Tax By Revenue	15.24x
Tr6m	-63.16%
Volume	0
Z Score	-3.06

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does NEO/CBST pay a dividend?

Capital-return profile for this ticker.

Performance

NEO/CBST stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns NEO/CBST?

Insider, institutional, and short-interest positioning.

Institutional ownership

+16.6%

Share of float held by funds and institutions

Insider ownership

+3.2%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

NEO/CBST momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

43.1

Neutral momentum band

Price vs 200-day MA

-61.1%

50/200-day relationship not available

Beta (5Y)

0.70

Less volatile than the market

Sharpe ratio

0.21

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About NEO/CBST

Hub-level FAQ points readers to the deeper analysis pages.

What is the current neo/CBST stock rating?

neo/CBST is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full neo/CBST analysis?

The full report lives at /stocks/neo/CBST/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for neo/CBST?

The latest report frames neo/CBST around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the neo/CBST page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.